Department News

Meet the 2026 DGH Husky 100 Winner

Please join us in congratulating the DGH Husky 100! Each year the Husky 100 program recognizes undergraduate, graduate and professional students from all three campuses who are making the most of their time at the UW. This year, DGH is proud to announce Doctor of Global Health Leadership and Practice student Mohammad Gazi as a member of the 2026 Husky 100 cohort!

Better understanding vaccine hesitancy: Preparing for a new tuberculosis vaccine

It has been over a hundred years since the first tuberculosis vaccine was invented, and yet tuberculosis remains the world’s deadliest infectious disease.  That is now poised to change. There are several new TB vaccines now in phase III clinical trials and the world is closer than ever to a breakthrough that could save 8.5 million lives by 2050. Yet questions remain regarding how well the new vaccines will be accepted b

1+1=3: How working together makes us more resilient

From environmental disasters, heated conflicts between countries and disease outbreaks, one word keeps popping up across headlines, research articles, and policy discussions: resilience – a concept deemed critical to addressing the complex challenges faced by humanity. 

Various resilience frameworks have highlighted the necessity of resilience across system, sectors, and levels (SSLs), where systems and sectors represent larger institutions, such as the health system, and levels represent smaller groups, such as communities or individuals.

In the Media

Washington’s hepatitis C elimination initiative expanded access to testing and treatment while reducing per-patient costs, UW-led study finds | UW News

UW News

Hepatitis C (HCV) is the most common bloodborne illness in the United States, and disproportionately impacts low-income people and marginalized communities.  A recent UW study evaluates the first-in-the-nation plan for coordination between public health agencies, increased screening, removal of barriers to care and a new approach to purchasing HCV antiviral medications at a discount. DGH professor Dr. Pamela Kohler is quoted.